Osiris
Therapeutics OSIR announced today that data, published in Ostomy
Wound Management, shows that the use of Grafix® on a variety of
chronic wounds resulted in an overall closure rate of 76% by 12 weeks,
including 68% of Venous Leg Ulcers (VLUs) and 85% of Diabetic Foot
Ulcers (DFUs) treated. The publication is available in the December 2013
issue of Ostomy Wound Management and on its website.
“The overall healing rate of 76% among recalcitrant wounds demonstrates
the profound effect Grafix had on my patients,” said Dr. Matthew
Regulski, lead author and Medical Director of
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in